bioAffinity Technologies Files 8-K

Ticker: BIAFW · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1712762

Sentiment: neutral

Topics: sec-filing, 8-k, regulatory

Related Tickers: BIAF

TL;DR

BIAF filed an 8-K on 7/23/25, check for updates.

AI Summary

On July 23, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. No specific financial transactions or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates bioAffinity Technologies, Inc. is providing updates or submitting required documentation to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification without specific details of material events or financial changes.

Key Players & Entities

FAQ

What specific 'Other Events' are reported in this 8-K filing?

The provided excerpt does not detail the specific 'Other Events' covered by the 8-K filing.

Are there any new financial statements or exhibits included with this filing?

The filing indicates 'Financial Statements and Exhibits' are included, but the excerpt does not provide their content.

What is the principal business of bioAffinity Technologies, Inc.?

bioAffinity Technologies, Inc. is in the 'SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH' sector, SIC code 8731.

When was bioAffinity Technologies, Inc. incorporated?

The company was incorporated in Delaware.

What is the SEC file number for bioAffinity Technologies, Inc.?

The SEC file number for bioAffinity Technologies, Inc. is 001-41463.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing